Tradolan retard 100 mg - Filmtabletten

Recall | Medicines | 13/05/2022

The marketing authorisation holder informed its customers on May 12, 2022, that it cannot be excluded that the package of the medicinal product „Tradolan retard 100 mg – Filmtabletten“ contains the non-related patient information leaflet of the medicinal product „Mirtel 30 mg – Filmtabletten“.

It is assumed that the information regarding intake, side effects and dosage of the prescription medicine is discussed with the attending physician.

The affected batch is recalled as a precaution.

Name of the medicinal product Tradolan retard 100 mg - Filmtabletten
Marketing authorisation number(s) 1-21255
CIP code 1347409
Marketing authorisation holder G.L. Pharma GmbH
Batch number(s) E08226
Expiry date 04/30/2025
Classification of the recall 2
Depth of recall Pharmacies
BASG reference number INS-640.001-3855

Further inquiry note